Invitrogen Corporation and Applied Biosystems Inc. announced the successful completion of their merger transaction. The new company will be named Life Technologies Corporation and is traded on the NASDAQ Global Select Market under the ticker symbol "LIFE" beginning November 24, 2008. “Thi ... more
QIAGEN and Applied Biosystems Settle all Disputes over Real-Time PCR Thermal Cycler Patents
Corbett, QIAGEN, ltf Labortechnik GmbH & Co. KG, and Applied Biosystems, LLC, part of Life Technologies Corporation announced a settlement of their disputes concerning infringement by Corbett’s Rotor-Gene_TM Real-Time PCR-Cyclers and Applied Biosystems’ Real-Time Thermal Cycler Instrument patents.
Applied Biosystems had filed an infringement lawsuit against Corbett in Germany and Corbett later filed a declaratory judgment lawsuit in California. Further, Corbett and ltf Labortechnik filed an intervention in opposition proceedings before the European Patent Office.
QIAGEN acquired Corbett, an Australian instrumentation manufacturing company, in July 2008. In connection with the settlement, Corbett has entered into an agreement with Applied Biosystems to take a license to certain technology relating to Corbett’s Real-Time PCR-Instrumentation and its use. The license covers all fields including research-related fields, applied fields and the fields of human and animal in vitro diagnostics. Financial terms of the settlement and related license agreement were not disclosed. These agreements fully resolve all pending disputes between Corbett, QIAGEN, ltf Labortechnik, and Applied Biosystems.
- Applied Biosystems
- LTF - Labortechnik
- Life Technologies
- license agreements
Drug toxicity is a leading cause of pre-clinical drug failures. The US Food and Drug Administration (FDA) and other regulatory organisations have called upon the pharmaceutical industry to develop more effective tools to help avoid these costly failures, reduce the number of failed compound ... more
Enigma Diagnostics Limited announced that it has signed a third licence agreement with Applied Biosystems. The licence provides Enigma with access to claims of US Patent No. 5,928,907 that describe methods for monitoring nucleic acid amplification in real-time. This is the first such licen ... more
QIAGEN announced the appointment of Thomas Ebeling, a leading international executive with extensive experience in the healthcare, media and consumer goods industries, as a member of the Supervisory Board with immediate effect. Mr. Ebeling joins QIAGEN as part of a process launched by the S ... more
QIAGEN N.V. announced the acquisition of the remaining 80.1% of diagnostics instruments company NeuMoDx Molecular, Inc. for $248 million in cash. The move rounds out QIAGEN’s portfolio of automated molecular testing solutions based on the proven PCR technology. The transaction was completed ... more
Thermo Fisher Scientific Inc. and QIAGEN N.V. announced that they have entered into an amendment to their acquisition agreement under which Thermo Fisher has commenced a tender offer to acquire all of the ordinary shares of QIAGEN. The amendment provides for an increase from the original of ... more
Thermo Fisher Scientific and Life Technologies Corporation have signed a definitive agreement under which Thermo Fisher will acquire Life Technologies for $76.00 in cash per fully diluted common share, or approximately $13.6 billion, plus the assumption of net debt at close ($2.2 billion as ... more
BAC BV has announced a strategic collaboration with Life Technologies to bring the wide range of BAC’s CaptureSelect® affinity ligand specificities to Life Technologies’ POROS® chromatography media and pre-packed HPLC columns. The collaboration will create a range of ready-to-use HPLC col ... more
Life Technologies Corporation announced it has signed a definitive agreement to sell its ownership stake in its mass spectrometry business, operated as a joint venture, to Danaher Corporation for $450 million in cash. Danaher has also signed an agreement to acquire Life Technologies’ joint ... more
- 1Smartphone-powered microchip for at-home medical diagnostic testing developed
- 2Measuring the ‘wettability’ of graphene and other 2D materials
- 3New method revolutionizes cancer diagnosis
- 4analytica 2022: Analytics that benefit consumer and environmental protection
- 5New technique shows in detail where drug molecules hit their targets in the body
- 6Bruker and TOFWERK Form Strategic Partnership
- 7Researchers demonstrate label-free super-resolution microscopy
- 8A sharper image for proteins
- 9Nanotechnology enables visualization of RNA structures at near-atomic resolution
- 10Why are neuron axons long and spindly?
- Microplastics found in human bloodstream
- Using ions to find molecules
- QIAGEN expands Supervisory Board with appointment of a new member
- Thermo Fisher Scientific and QIAGEN N.V. Agree on Amended Terms to Acquisition Agreement
- QIAGEN launches coronavirus test kit in Germany following derogation by BfArM